OGT certifies four CytoCell probes under IVDR for CLL and myeloma FISH testing, covering ATM deletion and IGH translocations NGS cannot yet replace ...

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and SPT Labtech today announced their partnership to deliver validated, automated library preparation workflows that combine Takara ...

GLP-1 receptor agonists have become the defining drug class of the decade. Initially developed to treat diabetes, they have exploded into the mainstream as powerful weight-loss agents, reshaping not ...

GLP-1 manufacturing challenges have become the binding constraint on one of the most successful drug classes in history. Demand for semaglutide and tirzepatide outran the industry’s ability to make ...

Researchers ​are beginning to uncover differences in brain metabolism and cognitive performance among people with PMOS, but ...

Explore how enzymatic DNA synthesis can support longer, more complex constructs for genome editing, mRNA, and synthetic ...

The field of drug discovery is undergoing a profound transformation. Traditional small-molecule and biologic therapeutics — long the backbone of modern medicine — are now joined by a new generation of ...

Discover how researchers are looking beyond individual neurons to understand how genetic variations shape activity across ...

Explore how dual binding assays reveal interactions between bispecific antibodies and their targets, providing insights into ...

The multi-omics data on nearly half a million tumor cells showed that even cells with almost identical genetic makeup can ...

Using bioinformatics and machine learning, scientists probe the depths of fungal genomes to find new compounds for undruggable cancers and infections. Fungi have been at war for millennia. Over the ...

This whitepaper outlines a practical framework for designing scientifically justified, regulatory-ready IND packages that ...